INTRODUCTION
The presence of an IUD in one horn of the uterus in rats (Parr & Segal, 1966; Parr, 1969; Saksena, Lau & Castracane, 1974) , rabbits (Ledger & Bickley, 1966) , hamsters (Saksena et al., 1974) , and goats (Janakiraman, Shukla, Gadgil & Buch, 1966) has been shown to cause an increase in the weight ofthat horn when compared with that of the control horn. It has been suggested that such an increase in weight and uniform growth is due to chronic inflammation even though administration of hydrocortisone failed to suppress such a response (Parr & Segal, 1966) .
It has been suggested that IUDs may act by releasing prostaglandins (Chaudhuri, 1971 ) and such a release has been shown to occur in rats (Chaudhuri, 1973; Saksena et al., 1974) and in ewes (Spilman & Duby, 1972) . On the basis of such a release, it has been speculated that a continuous release of prosta¬ glandins would lead to a persistent increase in the activity of the uterine horn, and that this could explain the hypertrophy associated with the presence of the device (Chaudhuri, 1973) .
The present experiments were carried out to see whether the hypertrophy of uterine horn caused by the introduction of a silk suture in the rat could be prevented by the administration of non-steroidal anti-inflammatory agents (Vane, 1971) , which inhibit the synthesis of prostaglandins.
MATERIALS AND METHODS
Female Wistar rats weighing between 170 and 210 g were used. Rats in dioestrus were anaesthetized with ether and the abdomen was opened by a mid-ventral incision. A silk thread 2-5 cm long was introduced into the f 77 lumen of one uterine horn and the ends tied to keep it in position. The contralateral horn was subjected to a sham operation and served as a control.
In addition, some rats were bilaterally ovariectomized at the time of intro¬ duction of the silk suture.
The non-ovariectomized animals were assigned to six groups and were injected subcutaneously (per kg body weight), starting from the day of opera¬ tion, with (1) hydrocortisone, 12-5 mg, (2) indomethacin, 2 mg, (3) aspirin, 10 mg or (4) aspirin, 100 mg, or (5) meclafenamate, 2 mg.
The rats in the sixth group received no treatment and served as controls.
The ovariectomized rats were assigned to two groups. Those in one group served as controls and the other rats were injected subcutaneously with 2 mg indomethacin/kg body weight.
The animals were killed by a blow on the head on the first day of dioestrus after the IUD had been in place for 15 days.
The uterine horns were dissected out and after being blotted slightly were immediately weighed in a Mettler balance for their wet weight. The tissues were then fixed in 10% formaldehyde and later were blotted and weighed again and then processed for histological examination.
The uterine weight refers to the whole horn, which was excised by cutting at the uterotubal and uterocervical junctions and by trimming away all the mesometrium. The silk suture was also removed before weighing. (Parr & Segal, 1966) , to an increased sensitivity to oestrogen, or to binding of oestrogen in the affected horn (Pincus, 1964; Kar, Goswami, Kamboj & Chowdhury, 1964) .
Since, however, hypertrophy of the uterine horn containing an IUD still occurs after administration of hydrocortisone (Parr & Segal, 1966) , a potent anti-inflammatory agent, and also when the animals are ovariectomized and adrenalectomized (Parr, 1969) , it seems probable that other factors in addition to inflammation or increased sensitivity to oestrogen may be involved.
It is now known that the spontaneous contractions of rat uterine horns are mediated by release of prostaglandins (Vane & Williams, 1973) and that the presence of an IUD is associated with an increase in the spontaneous motility of the horn in vitro compared to that of the control horn (Marcus, Marcus & Wilson, 1966) . This release of prostaglandin can be prevented in rats and ewes by administration of indomethacin (Chaudhuri, 1973; Spilman & Duby, 1972 Prostaglandins are released as a part of an inflammatory response (Moneada, Ferreira & Vane, 1973) and inflammation of the uterine horn is usually associated with the use of an IUD (Parr, 1970) . When released during inflamma¬ tion, prostaglandins intensify the effects of other inflammatory mediators and therefore aspirin-like drugs reduce but do not abolish the response to an inflammatory stimulus (Moneada et al., 1973) . This could explain the ability of meclafenamate, aspirin and indomethacin to reduce significantly, but not to abolish, the IUD-induced hypertrophy of the uterine horn in the present study. The inability of aspirin at the lower dose level to prevent such an hyper¬ trophy may have been due to the low doses used in this study.
The increase in weight of the uterine horns with an IUD seen in ovariecto¬ mized rats confirms the observations by Parr (1969) that hypertrophy of such horns can occur even in the absence of oestrogens. The ability of aspirin and indomethacin partly to prevent such an hypertrophy in ovariectomized animals, strengthens the rôle of prostaglandins in this process. Administration of oestro¬ gens (Wilson, 1963) or the presence of an IUD (Parr, 1969) causes nucleoli to appear in the endometrial and stromal cells of the uteri of ovariectomized animals where they are normally absent. Uterine inflammation may also be associated with an increase in nucleoli (Parr, 1969) and their presence may be an indication of the cellular activity involved in the proliferation of fibroblasts and deposition of ground substance (Parr, 1969) . Again, inflammation (Willis, 1969; Giroud & Willoughby, 1970) , oestrogens (Blatchley, Donovan, Horton & Poyser, 1972) and IUDs (Chaudhuri, 1973; Spilman & Duby, 1972; Saksena et al., 1974) have the common property of releasing prostaglandins. It is therefore possible that the hypertrophy of the uterine horn seen in these cases is mediated by such a release.
The present experiments clearly demonstrate that the IUD-induced hyper¬ trophy is mediated at least partly by prostaglandins.
